FI892946A0 - Menetelmä uusien terapeuttisesti käyttökelpoisten 2,3,4,5-tetrahydro-1H-3-bentsoatsepiinijohdannaisten valmistamiseksi - Google Patents
Menetelmä uusien terapeuttisesti käyttökelpoisten 2,3,4,5-tetrahydro-1H-3-bentsoatsepiinijohdannaisten valmistamiseksiInfo
- Publication number
- FI892946A0 FI892946A0 FI892946A FI892946A FI892946A0 FI 892946 A0 FI892946 A0 FI 892946A0 FI 892946 A FI892946 A FI 892946A FI 892946 A FI892946 A FI 892946A FI 892946 A0 FI892946 A0 FI 892946A0
- Authority
- FI
- Finland
- Prior art keywords
- bridge
- tetrahydro
- preparation
- therapeutically useful
- new therapeutically
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK325188A DK325188D0 (da) | 1988-06-15 | 1988-06-15 | Hidtil ukendte benzazepinderivater |
DK325188 | 1988-06-15 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI892946A0 true FI892946A0 (fi) | 1989-06-15 |
FI892946A FI892946A (fi) | 1989-12-16 |
FI93354B FI93354B (fi) | 1994-12-15 |
FI93354C FI93354C (fi) | 1995-03-27 |
Family
ID=8120790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI892946A FI93354C (fi) | 1988-06-15 | 1989-06-15 | Menetelmä uusien terapeuttisesti käyttökelpoisten 2,3,4,5-tetrahydro-1H-3-bentsoatsepiinijohdannaisten valmistamiseksi |
Country Status (15)
Country | Link |
---|---|
US (2) | US5010074A (fi) |
EP (1) | EP0347672B1 (fi) |
JP (1) | JP2769718B2 (fi) |
AT (1) | ATE102188T1 (fi) |
AU (1) | AU622911B2 (fi) |
CA (1) | CA1317938C (fi) |
DE (1) | DE68913367T2 (fi) |
DK (1) | DK325188D0 (fi) |
ES (1) | ES2061794T3 (fi) |
FI (1) | FI93354C (fi) |
IE (1) | IE891932L (fi) |
IL (1) | IL90533A (fi) |
NO (1) | NO173865C (fi) |
NZ (1) | NZ229521A (fi) |
PT (1) | PT90883B (fi) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK67489D0 (da) * | 1989-02-14 | 1989-02-14 | Novo Industri As | Nye benzazepinderivater |
US5158948A (en) * | 1990-11-16 | 1992-10-27 | Abbott Laboratories | Tetracyclic spirobenzazepine dopamine antagonists |
DK23392D0 (da) * | 1992-02-24 | 1992-02-24 | Novo Nordisk As | Heterocykliske forbindelser, deres anvendelse og fremstilling |
US5470850A (en) * | 1992-02-24 | 1995-11-28 | Novo Nordisk A/S | 2,3,4,5-tetrahydro-1H-3-benzazepines |
ES2203933T3 (es) | 1997-03-12 | 2004-04-16 | Addex Pharmaceuticals Sa | Utilizacion de 8-nitro-2,3,4,5-tetrahidro-1h-benzazepinas para la fabricacion de una composicion farmaceutica para el tratamiento de los trastornos de sueño. |
US6277844B1 (en) | 1998-09-14 | 2001-08-21 | Sydney Spector | Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis |
GB0130576D0 (en) * | 2001-12-20 | 2002-02-06 | Cenes Ltd | Dopamine D1 receptor agonist pro-drug compounds & derivatives |
JP4555685B2 (ja) * | 2002-08-29 | 2010-10-06 | シェーリング コーポレイション | 肥満およびcns障害の処置のための選択的d1/d5レセプターアンタゴニスト |
EP1572215B1 (en) | 2002-12-20 | 2009-09-02 | Glaxo Group Limited | Benzo[d]azepine derivatives for the treatment of neurological disorders |
JP2006526021A (ja) * | 2003-05-22 | 2006-11-16 | シェーリング コーポレイション | 肥満およびcns障害を治療する選択的d1/d5レセプタアンタゴニストとしての5h−ベンゾ[d]ナフト[2,1−b]アゼピン誘導体 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA974989A (en) * | 1968-03-11 | 1975-09-23 | Wallace And Tiernan Inc. | Process for preparing 1,2,4,5-tetrahydro-3h,3-benzazepines and products obtained thereby |
US4210749A (en) * | 1974-11-12 | 1980-07-01 | Pennwalt Corporation | Substituted 1,2,4,5-tetrahydro-3H,3 benzazepines |
ZA792044B (en) * | 1978-05-08 | 1980-05-28 | Scherico Ltd | Substituted 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof,and pharmaceutical compositions containing them |
US4327023A (en) * | 1980-01-31 | 1982-04-27 | Smithkline Corporation | Intermediates for preparing 7,8-amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines |
US4284556A (en) * | 1980-01-31 | 1981-08-18 | Smithkline Corporation | 7,8-Amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines |
DK180485D0 (da) * | 1985-04-22 | 1985-04-23 | Novo Industri As | Nitrogenholdige forbindelser |
AU588080B2 (en) * | 1986-01-16 | 1989-09-07 | Schering Corporation | Fused benzazepines |
EP0244088A3 (en) * | 1986-04-03 | 1989-03-15 | Smithkline Beecham Corporation | 1-phenyl-3-benzazepine compounds and medicaments containing these compounds for treating gastrointestinal motility disorders |
-
1988
- 1988-06-15 DK DK325188A patent/DK325188D0/da not_active Application Discontinuation
-
1989
- 1989-06-05 IL IL9053389A patent/IL90533A/en unknown
- 1989-06-09 ES ES89110490T patent/ES2061794T3/es not_active Expired - Lifetime
- 1989-06-09 AT AT89110490T patent/ATE102188T1/de not_active IP Right Cessation
- 1989-06-09 EP EP89110490A patent/EP0347672B1/en not_active Expired - Lifetime
- 1989-06-09 DE DE68913367T patent/DE68913367T2/de not_active Expired - Lifetime
- 1989-06-12 US US07/365,250 patent/US5010074A/en not_active Expired - Lifetime
- 1989-06-13 NZ NZ229521A patent/NZ229521A/en unknown
- 1989-06-13 CA CA000602684A patent/CA1317938C/en not_active Expired - Lifetime
- 1989-06-14 AU AU36359/89A patent/AU622911B2/en not_active Expired
- 1989-06-14 NO NO892476A patent/NO173865C/no not_active IP Right Cessation
- 1989-06-15 FI FI892946A patent/FI93354C/fi active IP Right Grant
- 1989-06-15 IE IE891932A patent/IE891932L/xx not_active IP Right Cessation
- 1989-06-15 JP JP1150662A patent/JP2769718B2/ja not_active Expired - Lifetime
- 1989-06-15 PT PT90883A patent/PT90883B/pt not_active IP Right Cessation
-
1990
- 1990-02-07 US US07/477,450 patent/US5025009A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA1317938C (en) | 1993-05-18 |
IL90533A0 (en) | 1990-01-18 |
DK325188D0 (da) | 1988-06-15 |
JP2769718B2 (ja) | 1998-06-25 |
NO892476D0 (no) | 1989-06-14 |
US5010074A (en) | 1991-04-23 |
PT90883B (pt) | 1994-12-30 |
PT90883A (pt) | 1989-12-29 |
NZ229521A (en) | 1991-12-23 |
IL90533A (en) | 1994-05-30 |
FI892946A (fi) | 1989-12-16 |
NO173865B (no) | 1993-11-08 |
ATE102188T1 (de) | 1994-03-15 |
US5025009A (en) | 1991-06-18 |
IE891932L (en) | 1989-12-15 |
EP0347672B1 (en) | 1994-03-02 |
AU3635989A (en) | 1989-12-21 |
NO892476L (no) | 1989-12-18 |
DE68913367T2 (de) | 1994-06-01 |
FI93354B (fi) | 1994-12-15 |
NO173865C (no) | 1994-02-16 |
FI93354C (fi) | 1995-03-27 |
ES2061794T3 (es) | 1994-12-16 |
EP0347672A1 (en) | 1989-12-27 |
AU622911B2 (en) | 1992-04-30 |
DE68913367D1 (de) | 1994-04-07 |
JPH0240364A (ja) | 1990-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI113651B (fi) | Menetelmä terapeuttisesti käyttökelpoisten bentsimidatsoliyhdisteiden valmistamiseksi | |
NO1998008I1 (no) | Naratriptan | |
GB8819024D0 (en) | Chemical compounds | |
FI892946A0 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 2,3,4,5-tetrahydro-1H-3-bentsoatsepiinijohdannaisten valmistamiseksi | |
FI884553A0 (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisten 9-aminotetrahydroakridiinijohdannaisten valmistamiseksi | |
DK0430201T3 (fi) | ||
HU9201887D0 (en) | Process for the production of //aralkyl-piperidine-4-yl/-methyl/-2a,3,4,5-tetrahydro-1-/2h/-acenaphtylene-1-on derivatives and of medical preparations containing them as active agents | |
FI893682A (fi) | Menetelmä terapeuttisesti käyttökelpoisten 1,2,5-ditiatsosiinijohdannaisten valmistamiseksi | |
PT87005A (pt) | Process for preparing n-phenethylaminoalkyl-benzamide anti-arrhythmic agents | |
ATE56432T1 (de) | Substituierte 1,3,4,9-tetrahydropyrano(3,4b>indole-1-essigs|ure. | |
GR3006108T3 (fi) | ||
DK424888A (da) | Naphthothiazepinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende saadanne derivater | |
AU7589298A (en) | 5-{(heteroaryl)alkyl}-3-oxo-pyrido{1,2-(a)}benzimidazole-4-c arboxamide derivatives useful in treating central nervous system disorders | |
NO162859C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oksadiazolylimidazobenzodiazepinforbindelser. | |
FI933928A (fi) | Heteroarenylpiperaziner, foerfarande foer framstaellning av dessa och anvaendning som laekemedel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
FG | Patent granted |
Owner name: ADDEX PHARMACEUTICALS SA |